We place a strong emphasis on research, because it is essential to discovering more effective ways to prevent and treat cancer. Many of our scientists focus their work on metastatic prostate cancer (prostate cancer that has spread to other organs), which is incurable.
- One of our teams has identified two “gatekeeper” genes that enable prostate cancer to escape the effects of treatment. This information can help researchers zero in on those genes in the hope of developing treatments that will shut them down.
- Other Roswell Park researchers are conducting clinical trials of new immunotherapies for those with metastatic prostate cancer that has progressed in spite of treatment.
- We have discovered a genetic profile in patients whose prostate cancer comes back after androgen-deprivation therapy. This may help us identify aggressive and potentially fatal prostate cancers sooner and find ways of combining treatments that could prevent those cancers from recurring after treatment.